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Background: Totally implantable venous access devices can be implanted both by percutaneous approaches and
by surgical approaches with cephalic vein or external jugular vein cut-down techniques that are related to low
intraoperative complication rates. The authors report a prospective evaluation of 83 consecutive external jugular
vein cut-down approaches for totally implantable venous access devices implantation.
Methods: Eighty three consecutive patients (28 M, 55 F, mean age 54.2) suffering from solid tumors (58) or
hematologic diseases (25) were consecutively submitted to totally implantable venous access devices insertion
through external jugular vein cut-down approach (75 on right side, 8 on left side).
Results: All devices were surgically implanted; no instances of intraoperative complications were detected. After a
minimum follow-up of 150 days, only one case of wound hematoma and one case of device malfunction due to
incorrect catheter angulation were noted.
Postoperative patient satisfaction was evaluated by the use of specific questionnaire that demonstrated a good
satisfaction and compliance (92.8 %) of patients with implanted devices.
Conclusions: Despite the lack of controlled studies comparing external jugular vein cut-down approach vs other
approaches, this approach should be considered as a tool for long-term central vein catheters positioning, both as
an alternative and for primary approach.Background
Totally implantable venous access devices (TIVADs) are
usually inserted and utilized in case of long-term therap-
ies and nutritional support in oncologic patients [1, 2].
These devices can typically be implanted through differ-
ent ways. The percutaneous approach is the most used
technique and can be performed under ultrasound guid-
ance or “blind” puncture, via the subclavian or internal
jugular vein (using the Seldinger technique) [1]; never-
theless, this approach is still affected by several and
potentially severe complications, like pneumothorax,
hemothorax, vascular, or brachial plexus injuries, oc-
curring in up to 12 % of patients [3, 4]. On the other
hand, cephalic vein cut-down (CVCD) technique appears
to be effective and not affected by these severe compli-
cations [3–5] but is reported to fail in 6–30 % of cases,
mainly due to anatomic variations in cephalic vein course* Correspondence: giuseppe.cavallaro@uniroma1.it
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cess rates in positioning TIVAD via the external jugular
vein (EJV) by cut-down approach [3–5].
The authors report a prospective evaluation of 83
consecutive EJV cut-down (EJV-CD) approach proce-
dures for TIVAD implantation, evaluating success rates,
intraoperative and postoperative complications, and
patient satisfaction.
Methods
From January 2014 to June 2014, 83 consecutive patients
(28 M, 55 F, mean age 54.2) suffering from solid tumors
(58) or hematologic diseases (25) were consecutively
submitted to TIVAD implantation through EJV-CD
approach (75 on right side, 8 on left side). Patient char-
acteristics, oncological diagnosis, and comorbidities are
summarized on Table 1. All devices used were Celsite®
ST201F (B.Braun Medical, 92107 Boulogne Cedex –
France), with 6.5 Fr. silicone catheter, and 0.035-in.
guidewire.le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Table 1 Patients demographics and characteristics
Gender (M/F) 28/55
Mean age 54.8 ± 16.4
Comorbidities
Diabetes 18
Morbid obesity (BMI >35) 4
COPD 7
Cardiovascular disease 21
Hypertension 42
Oncologic diagnosis
Gastrointestinal 31
Breast 12
Lung 9
Hematological 25
Other 6
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prophylaxy 30 min before surgery.
Implantation technique
All procedures were performed by the same surgeon
(GC) having large experience in TIVAD implantation.Fig. 1 Technique of TIVAD implantation, on the left side. The head is rotat
c The catheter is inserted into the vein. d Intraoperative fluoroscopy revealAll devices were implanted in the operating theater
under fluoroscopic control, and patients were treated
and monitored in a day hospital setting. Seventy five
TIVADs were inserted on the right side, and, due to
right breast or lung cancer or to previous TIVAD or
other central venous catheter implantation on the right
side, the other eight were implanted on the left side. The
route of the external jugular vein was identified and
marked by a permanent marker prior to surgery, by
placing the patient in mild Trendelemburg position
and using the Valsalva maneuver (Fig. 1a). After local
anesthesia (2 % solution of mepivacaine hydrocloride),
1.5-cm skin incision was performed on the neck skin.
After careful dissection of subcutaneous space, the
EJV was identified and exposed (Fig. 1b) Then, the cath-
eter was inserted (Fig. 1c) into the vein for about 15 cm.
The correct positioning of the catheter tip was controlled
by fluoroscopy (Fig. 1d). So the catheter was connected to
the port (placed in a subfascial pocket on the pectoralis
muscle) through a subcutaneous tunnel (using the specific
device present in the TIVAD sterile package). In 14 cases
(16.9 %), due to difficult progression of the catheter
through the vein lumen, a J-tip guidewire inserted into the
catheter lumen was used to facilitate the progression. At
the end of the procedure, a test puncture was performeded to the right. a The route of the left EJV. b The EJV is identified.
s the good positioning of the catheter tip just above the right atrium
Table 3 Patient questionnaire to assess changes in TIVAD
implantation (taken from: Faigo JL. Quality of life and Patients
Satisfaction. In: Di Carlo I, Biffi R. Totally implantable venous
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sodium heparin solution (5000 IU in 10 ml of 0.9 % saline
solution).access devices: management in mid and long-term clinical
settings. Springer Eds, 2012; 37: 265–268. DOI: 10.1007/978-88-
470-2373-4. ISBN: 978-88-470-2372-7)
Table query Yes (%) No (%)
Were you well informed about the
surgical procedure?
79 (95.1 %) 4 (4.9 %)
Did you feel supported during
the operation?
76 (91.5 %) 9 (8.5 %)
Was the procedure painful? 11 (13.2 %) 72 (86.8 %)
Did the procedure take too long? 10 (12.0 %) 73 (88.0 %)
Were you provided with adequate
information about the catheter?
80 (96.4 %) 3 (3.6 %)
Would you repeat the procedure
under local anesthesia?
75 (90.4 %) 8 (9.6 %)
Would you repeat the procedure in
a day hospital setting?
81 (97.5 %) 2 (2.5 %)
Would you counsel a friend or relative
to undergo such a procedure under
the same conditions?
76 (91.5 %) 9 (8.5 %)
Were your preoperative fears and
expectations realized?
15 (18.1 %) 68 (81.9 %)
Did the TIVAD affect your daily living? 6 (7.2 %) 77 (92.8 %)Results
Intraoperative and postoperative results and compli-
cations are summarized in Table 2. All TIVADs were
surgically implanted, with no need of percutaneous ac-
cess to sublcavian or internal jugular veins. We found
no differences in operative time between left and right
side. No instances of intraoperative complications, such
as pneumothorax, hemotorax, injuries to great vessels,
or brachial plexus were detected. After a minimum
follow-up of 150 days only one case of wound hematoma
and one case of device malfunction due to excessive cath-
eter angulation requiring surgical revision of the catheter
were noted. No cases of deep venous thrombosis or cath-
eter rupture were noted.
Postoperative patients satisfaction was evaluated by
the use of specific questionnaire on postoperative satis-
faction after TIVAD implantation (Table 3) [6]. The re-
ported results demonstrated a good satisfaction about
the surgical procedure and outcome and a good compli-
ance (92.8 %) of patients with implanted devices.Did the TIVAD facilitate the treatment? 81 (97.5 %) 2 (2.5 %)Discussion
EJV approach represents an effective way for accessing
the central venous system, reducing severe complications
related to deep vein puncture: pneumothorax, hemotho-
rax, arterial or nerve injuries, and deep venous thrombosis
[7–12], and it is currently used for many kinds of central
venous catheters (mainly dyalisis and Groshong catheters)
especially in pediatric patients [13–17], reporting low
complication rates and higher success rates, even in emer-
gency and intensive care settings [18–22].
Nevertheless, only few reports dealing EJV approach
for TIVAD implantation exist.
However, a recent literature review [23] and other previ-
ous studies [3, 24] support the evidence that approachesTable 2 Intraoperative and postoperative results
Side of implantation (R/L) 75/8
Operative time
Right side 18.2 min (range 11–36)
Left side 19.4 min (range 14–35)
Success rate 83/83 (100 %)
Use of guidewire 14/83 (16.9 %)
Intraoperative complications 0/83 (0 %)
Postoperatve complications 2/80 (2.5 %)
Wound hematoma 1
Device malfunction 1to the EJV (both cut-down and percutaneous) are safe and
effective even for TIVAD implantation.
The present prospective study on 83 primary EJV-CD
approaches for TIVAD implantation report a 100 % suc-
cess rate and a very low incidence of complications
(2.4 %); furthermore, only one of these complications
appears related to the specific technique itself and spe-
cifically to an incorrect angulation of the catheter when
entering the EJV. This low incidence of complications is
due to a totally surgical approach, with no direct vein
puncture, and to the easy dissection and identification
of the vein that runs superficially and can be easily
detected preoperatively, by placing the patient in mild
Trendelemburg position and after Valsalva maneuver.
In 14 patients, due to a difficult progression of the
catheter from the EJV to the right atrium, we used a
J-tip guidewire to ensure the correct catheter positioning.
Difficulties in catheter progression through the vein route
are mainly due to a sharp angulation between the EJV and
the subclavian vein, occurring in about 12 % of patients,
as recently demonstrated by radiological evaluations
[25, 26]. However, the simple use of the guidewire within
the catheter lumen allowed a correct progression of the
catheter until the right atrium.
Despite the high success and low complication rates
reported by this prospective evaluation, as well as by
previous studies, there are still several controversies
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TIVAD implantation. First, the need to perform two sep-
arate incisions (one for EJV catheterization and one for
the subfascial pocket for the Port) and second, the need
to make a subcutaneous tunnel for the catheter and the
consequent risk to create an obstacle (angulation) to the
catheter flow, just near the EJV inlet. This occurrence
can be avoided by creating a “gentle” shape to the cath-
eter curve near the EJV inlet, and actually, there is no
evidence that the subcutaneous tunnel itself may be
related to any complication or TIVAD malfunction. An-
other criticism related to the presence of the tunneled
catheter is the possible discomfort of patients about the
presence of the catheter in subcutaneous tissues of the
neck and above the clavicule that can give a “foreign
body” sensation and perceived as not esthetic. For these
reasons, we proposed, 30 days after surgery, a specific
patient satisfaction questionnaire designed for TIVAD
implantation [6]. Results of this questionnaire, summa-
rized in Table 3, reflect a good patient satisfaction and
compliance (in 92.8 % of cases) with TIVAD implanted
through the EJV, thus encouraging us to continue in this
experience.
Conclusions
In conclusion, this prospective evaluation reports a
100 % success rate in TIVAD implantation through
EJV-CD approach, with very low incidence of compli-
cations and high levels of patient satisfaction, demon-
strated by a dedicated questionnaire. So, despite the
lack of controlled studies comparing EJV-CD approach vs
other approaches that cannot lead to definitive conclu-
sions about the “gold standard” technique, we can say that
this approach should be considered at least as a tool for
long-term central vein catheters positioning, both as an
alternative and for primary approach.
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